Questions about a product, technology or experimental design? Give us a call 610-644-8845. For special institutional pricing, check out our Distributors!
Questions about a product, technology or experimental design? Give us a call 610-644-8845.

Phospho-Ubiquitin as a Biomarker

Advancing neurodegeneration research through innovative ubiquitin proteasome system analysis

The Ubiquitin Proteasome System (UPS) is the guardian of the cell. It removes damaged proteins and organelles and keeps the intracellular protein traffic running smoothly. In both Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) the accumulation of protein aggregates, such as α-synuclein and tau, depolarize mitochondria. Dysfunctional mitochondria and loss of ATP is the main cause of neuronal cell death. We believe that dysfunction in the UPS is the root cause of neurodegeneration. Novel and groundbreaking therapeutics are emerging by targeting the UPS. LifeSensors is at the forefront of neurodegeneration research and the discovery of neuronal biomarkers.

UPS

Ubiquitin Proteasome System
The cellular guardian maintaining protein homeostasis

α-Syn

Alpha-Synuclein Aggregates
Key pathological marker in Parkinson’s Disease

Tau

Tau Protein Aggregates
Critical biomarker in Alzheimer’s Disease

The Ubiquitin Proteasome System (UPS) is the guardian of the cell. It removes damaged proteins and organelles and keeps the intracellular protein traffic running smoothly. In both Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) the accumulation of protein aggregates, such as α-synuclein and tau, depolarize mitochondria.

Dysfunctional mitochondria and the resulting loss of ATP is the main cause of neuronal cell death. We believe that dysfunction in the UPS is the root cause of neurodegeneration. Novel and groundbreaking therapeutics are emerging by targeting the UPS. LifeSensors is at the forefront of neurodegeneration research and the discovery of neuronal biomarkers.

Key Research Focus Areas

Clinical Significance

Parkinson's Disease affects over 10 million people worldwide. Understanding the molecular mechanisms underlying in neurodegeneration is crucial for developing effective therapeutic interventions. The UPS plays a central role in maintaining cellular protein homeostasis, and its dysfunction is increasingly recognized as a key contributor to neurodegenerative pathology.

Mutations in Parkin (an E3 ubiquitin ligase) and PINK1 (PTEN-induced kinase 1) are associated with early-onset forms of the disease. Parkin functions as an E3 ubiquitin ligase, tagging damaged or unwanted proteins for degradation by the proteasome. PINK1, on the other hand, plays a role in mitochondrial quality control and the maintenance of cellular homeostasis. Dysfunctional Parkin and PINK1 pathways contribute to mitochondrial dysfunction and oxidative stress, key factors in Parkinson’s pathology.

PINK1 Kinase

PTEN-induced kinase 1 – Mitochondrial quality control sensor

Parkin E3 Ligase

E3 ubiquitin ligase – Protein degradation executor

When mitochondria are damaged, PINK1, a mitochondrial kinase, is stabilized to generate phospho-ubiquitin. Phospho-ubiquitin binds to Parkin, activating the cytosolic E3 ligase. Activated Parkin builds phospho-polyubiquitin chains to induce autophagy, mitophagy, and mitobiogenesis. Mitochondria exploit the UPS and Parkin to repair the damage. Mutations in PINK1 and Parkin lead to neurodegeneration. A remarkable series of experiments demonstrate that mitochondria conspire to recruit the UPS by phosphorylating ubiquitin by PINK1 kinase and jumpstarting Parkin ligase. Nature is elegant, the UPS needs ATP to function, and mitochondria needs the UPS to repair itself and prevent neurodegeneration.

Step-by-Step Molecular Pathway

Loss of membrane potential triggers PINK1 accumulation on the outer mitochondrial membrane
PINK1 phosphorylates ubiquitin at Ser65, creating a unique molecular signal
Phospho-ubiquitin binds to Parkin, inducing conformational changes and E3 ligase activation

Activated Parkin builds K63-linked polyubiquitin chains on mitochondrial substrates

Polyubiquitinated mitochondria are recognized by autophagy receptors, triggering selective degradation

Mitobiogenesis replenishes healthy mitochondria, maintaining cellular energy balance
Our comprehensive portfolio of research tools enables cutting-edge investigations into neurodegenerative mechanisms

Phospho-ubiquitin Antibodies

High-affinity, validated antibodies for detecting and quantifying phosphorylated ubiquitin species

Phospho-ubiquitin Chains

Synthetic and recombinant phospho-ubiquitin chains and derivatives for mechanistic studies

Neuronal DUBs and Ligases

Deubiquitinases and E3 ligases critical for neuronal protein homeostasis

PINK1 and Parkin Pathway Proteins

Complete set of recombinant proteins for studying mitochondrial quality control

Enriched Lysates

Phospho-polyubiquitinated protein enriched lysates from neuronal sources

TUBEs

Tandem Ubiquitin Binding Entities for selective enrichment of ubiquitinated proteins

UbiQuant™ for Phospho-Polyubiquitination

Quantitative mass spectrometry-based platform for comprehensive ubiquitin profiling

PROTAC Approaches for Tauopathies and α-Synucleinopathies

PROteolysis TArgeting Chimeras (PROTACs) represent a revolutionary therapeutic strategy for selectively degrading disease-causing proteins. Our PROTAC platforms target pathological tau and α-synuclein aggregates, offering novel approaches to treating neurodegenerative diseases.

Research Services on E3 Ubiquitin Ligases

Comprehensive research services for characterizing E3 ligase function, substrate identification, and drug discovery. Our expert team provides custom assay development, screening services, and mechanistic studies.

Biomarker Development for Parkinson's Disease / Alzheimer's Disease

Advanced biomarker discovery and validation services focused on early detection and disease monitoring. Our platforms enable identification of novel diagnostic and prognostic markers for neurodegenerative diseases.

PD Research Products

Extensive catalog of specialized reagents, antibodies, proteins, and assay kits specifically designed for Parkinson's Disease research. All products are rigorously validated and quality controlled.

Phospho-ubiquitin is an alarm bell and a biomarker for neurodegeneration. LifeSensors has developed high affinity tools to enrich phospho-ubiquitin and phospho-Parkin from brain tissue, CSF, and serum. These tools can be applied for developing ultra-sensitive assays for biomarker development and diagnostic applications. LifeSensors has developed unique HTS (High-Throughput System) assays for discovering Parkin modulators. LifeSensors is also developing novel biomarkers for PD and AD.

Product / Tools Name

SKU

Categories

Add to cart

Menu

Learning Center